Last updated
Anti Fund: Capital Raising
Anti Fund, a venture capital firm associated with Jake Paul, is raising a second fund targeting $400 million in commitments
Source: Axios deals (GN)
- What happened
- Anti Fund, a venture capital firm associated with Jake Paul, is raising a second fund targeting $400 million in commitments
- Who
- Anti Fund · USA
- When
- 2026-10-01
- Source
- Axios deals (GN)
- So what
- A fund close is a deployment signal, not a hiring one.
The leadership read
A fund close is a deployment signal, not a hiring one. Anti Fund will put this capital to work rather than build its own bench, and the leadership demand shows up downstream: in the companies it backs, on a six to eighteen month lag. Watch which Americas businesses take the cheque; that is where the mandates form.
Market context: Backdrop: a 122.7 (Hot) Talent Market Index (up 17.8 on the month) with Americas activity rising (+34.4pts).
Anti Fund: 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across Americas
Capital Raising · Americas
Antheia →Antheia, an advanced biosynthesis pharmaceutical manufacturer, secured an $80 million conditional funding commitment from the Department of War's Office of Strategic Capital to support domestic onshoring of critical medicine supply chains.
Capital Raising · Americas
Klook Technology →Hong Kong-based travel booking platform Klook Technology has filed to withdraw its US IPO, which it had filed for in November 2025.
Capital Raising · Americas
Swamp Club →San Francisco-based AI agent platform Swamp Club raised a $7M seed round led by Amplify Partners, with Encoded Ventures and angels participating. Funds will scale its behavior-centric AI agent platform for enterprise production use.
Capital Raising · Americas
EMode Photonix →Boulder, Colorado photonics simulation software startup EMode Photonix raised a $1M pre-seed round led by Ground State Ventures, with Harlow Capital Management participating.
Capital Raising · Americas
Frazier Life Sciences Acquisition Corp →Frazier Life Sciences is taking a biotech-focused SPAC public on Nasdaq, a blank-check vehicle raising capital to acquire a life sciences company.
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record